Funding Layoffs Report San Diego 
TechCrunch LA
APRIL 6, 2020
I’m your host Kirsten Korosec, senior transportation reporter at TechCrunch. metro area, San Diego and Santa Monica. Spin, which began offering this on April 1, is making this available in Baltimore, Denver, Detroit, Los Angeles, Portland, San Francisco, Tampa and Washington, D.C. That’s what you’re reading now.
socalTECH
DECEMBER 11, 2009
San Diego-based Verari Systems , a developer of blade server technology, has shut down, according to publication InsideHPC. Verari had raised over $59M in funding from such investors as Carlyle Group, Celerity Partners, Sierra Ventures, and Voyager Capital. READ MORE>>. READ MORE>>.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
OCTOBER 7, 2016
military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. The funding could be as much as $100 million, and the first grants will be announced in 2017. Shares immediately fell more than 40 percent.
Xconomy
JULY 1, 2016
But as Xconomy reported, details about the reorganization were scant, leaving open questions whether drug regulation actually needs to move faster. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab. Buzzfeed reports that Katze is still drawing his UW salary, but his lab has been shut down.
Xconomy
JULY 15, 2016
Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. million in funding, according to a regulatory filing. The week started on a reflective note. —Enough good trial news. —In other Merck news, U.K. —With $1.25
Xconomy
JUNE 30, 2017
The nonpartisan Congressional Budget Office report Monday put the bill’s potential effects in stark relief: $321 billion in deficit reduction because of tax cuts and a Medicare rollback, and 22 million more people uninsured by 2026.
Xconomy
JUNE 17, 2016
The filing held some surprises , however, as Xconomy reported: plans to convert about $200 million in debt—a massive amount for a privately held biotech—into shares at the IPO, with some of those shares holding special privileges for their owners. . —Ben Fidler contributed to this report. Reprints | Share:
Expert insights. Personalized for you.
136 
Let's personalize your content